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Abstract
Toxicology is about to establish itself as a leading scientific discipline in addressing potential health
effects of materials on the nanosize level. Entering into a cutting-edge field, has an impact on
identity-building processes within the involved academic fields. In our study, we analyzed the ways
in which the entry into the field of nanosciences impacts on the formation of disciplinary identities.
Using the methods of qualitative interviews with particle toxicologists in Germany, Holland,
Switzerland and the USA, we could demonstrate that currently, toxicology finds itself in a
transitional phase. The development of its disciplinary identity is not yet clear. Nearly all of our
interview partners stressed the necessity of repositioning toxicology. However, they each
suggested different approaches. While one part is already propagandizing the establishment of a
new discipline – 'nanotoxicology'- others are more reserved and are demanding a clear separation
of traditional and new research areas. In phases of disciplinary new-orientation, research
communities do not act consistently. Rather, they establish diverse options. By expanding its
disciplinary boundaries, participating in new research fields, while continuing its previous research,
and only vaguely defining its topics, toxicology is feeling its way into the new fields without giving
up its present self-conception. However, the toxicological research community is also discussing a
new disciplinary identity. Within this, toxicology could develop from an auxiliary into a constitutive
position, and take over a basic role in the cognitive, institutional and social framing of the
nanosciences.
Background
Nanosciences shaping disciplinary identities
The nanosciences and -technologies are interdisciplinary
research fields, which developed over the past two dec-
ades at the interface of physics, chemistry, biology, molec-
ular biology and material sciences. The field researches the
structure of material characteristics and functions on the
nanometer scale. On the nano-scale quantum effects
affect the behavior of matter in a consequential way. This
phenomenon allows for the analysis of new material
properties and a variety of applications. Nanosciences and
-technologies are currently considered as leading innova-
tion fields [1]. Hardly any other cutting-edge science has
been able to generate such comprehensive expectations
regarding its developmental potential. Globally, annual
investment in research and development within this field
exceed the billion-dollar mark [2]. Furthermore, almost
no industrial nation can afford not to establish national
programs and no academic institution, not to initiate
research initiatives in this area. This opens the possibility
for a number of scientific disciplines to participate in this
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area and adapt their research to related issues and objec-
tives.
Apart from the scientific and economic euphoria, various
social actors have started to debate the potential implica-
tions of these new scientific and technical developments.
A variety of researchers and institutions have begun to
investigate the potential ethical, social and environmental
effects of nanosciences and -technologies. On the one
hand, nano-scientists themselves have been addressing
such issues, e.g., the joint founder of Sun, Bill Joy, who
published a manifesto in the magazine Wired [3]. On the
other hand, technology-critical civil society organizations
focus their activities on nanosciences and -technologies,
e.g. the 'Center for Responsible Nanotechnology' [4], the
Action Group on Erosion, Technology and Concentration
(ETC), Canada [5], as well as Greenpeace [6]. Further-
more, social and political institutions, like the Royal Soci-
ety in UK [7], the European Commission [8] and several
national technology assessment institutions [9] have
addressed potential risks of nanosciences and technolo-
gies.
In addition, spectacular visions and Utopias as well as
dystopic scenarios have been formulated and discussed in
media and on the literary level. A well-known example is
the 'grey goo' scenario, which, for example, was pointed
out in the Drexler-Smalley debate and was addressed by
Michael Crichton in his novel 'Prey'. The negotiation of
fictions in the debate between Eric Drexler and the nobel
laureate Richard Smalley focused on the question of the
feasibility of molecular assemblers [10]. Drexler is seen as
the founder of the idea of machines, which develop
objects atom by atom and replicate themselves [11].
Smalley, as a representative of classical chemistry, tried to
disprove the futuristic approach of Drexler. He argued that
such Utopian ideas could encourage public fear of a loss
of control over such machines and of their unlimited
spread ('grey goo') and this in turn could damage the rep-
utation of nanotechnologies as a whole. The taking up of
grey goo' scenarios by the Prince of Wales, was widely dis-
cussed into the popular media and led to a Royal Society
report on the chances and uncertainties of nano-sciences
and technologies [12]. Relevant fictions have also
appeared in novels of Anderson, Asimov, Bear and
Stephenson [13]. Michael Crichton describes, in possibly
his most famous novel, 'Prey', a 'grey goo' scenario involv-
ing the loss of control over nano-technologically manu-
factured micro robots, 'nanobots' [14].
Such discourses have crucially contributed to the demand
for a moratorium on the technological development and
production of nano-materials made by civil society organ-
izations like for example the Canadian ETC-group [15].
Furthermore, a moratorium on the development of nano-
materials was proposed to national government leaders at
the world summit for sustainable development in Johan-
nesburg 2002 [16]. In addition, the manifesto of Bill Joy
is occasionally interpreted as a call for a moratorium
stressing the unforeseeable risks of nanotechnologies. Joy
makes comparison to the development of the atom bomb
and pleads for deeper ethical reflection on the nano-
sciences and -technologies [3].
Beside these more future-oriented risk discourses, how-
ever, tangible health effects of particles at the nanometer
scale have been detected by a variety of toxicological
working groups [17]. So far, concrete findings regarding
potential risks of nanosciences and -technologies focus on
the health implications of particles at the nanometer
scale. This field addresses those scientific disciplines, hav-
ing methodological and textual experience in the investi-
gation of the bio-reactivity of particles and materials for its
analysis. In this context, toxicology as a scientific disci-
pline plays a responsible role. Toxicology has traditionally
examined the potential harmful effects of chemical or
physical agents on biological systems. While nanosciences
and -technologies do not yet form a coherent program,
toxicology sees itself as contributing to the public dis-
course with technically clear and concise answers, broadly
recognized in the media. Early exponents in the toxicolog-
ical research community are already claiming the emer-
gence of nanotoxicology as a new discipline [18] and a
new journal with the title 'Nanotoxicology' has been
launched in 2005 by the Taylor and Francis group [19].
Before explaining the aim of this study, our hypothesis
and what will be reported in this article, we will give a
short explanation of our theoretical model: The formation
of disciplinary identities can be analyzed using theories of
the development and differentiation of scientific disci-
plines [20]. Toxicology as a scientific discipline under-
stands itself through its orientation toward externally
defined problems like for example the supply of practical
guidelines for the adjustment of toxic chemicals. There-
fore, the concept of 'Finalisierung – finalization' [21]
plays an important role in the analysis of the construction
of disciplinary identities. The concept of 'finalization'
focuses on the influence of internal and external factors
and orientations within the development of science. Boe-
hme et al. and van den Daele and Weingart developed this
approach in the 1970s and were influenced by Luhmann's
system theory and Kuhn's theses of scientific progress
[22]. Van den Daele and Weingart base their theory on
three variables influencing the differentiation of scientific
disciplines: cognitive, institutional and political aspects.
Cognitive aspects describe factors, which define science as
an intellectual enterprise [20].Particle and Fibre Toxicology 2006, 3:6 http://www.particleandfibretoxicology.com/content/3/1/6
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Furthermore, cognitive aspects specify the development of
a discipline and consist of such things as internal struc-
tures and epistemic practices [23]. In contrast, institu-
tional aspects focus on internal processes within scientific
institutions, such as co-operation, communication and
interpersonal relationships. Such processes determine sci-
ence as a social operation system and they differentiate
new research fields [24]. Political aspects are understood
in terms of science-policy attitude and demand a 'product
value orientation' from science. In this way, science is con-
trolled by political interests and orientated toward the
solution of specific, socially induced and politically
defined problems like cancer- or environmental research
[25]. Thus, in our study we will and use the term 'external
aspects' instead of 'political aspects', considering beside of
politically, also socially and economically relevant crite-
ria. According to this account, disciplinary development
takes place via different contexts: on the one hand, by cog-
nitive and institutional aspects that are internal to science,
on the other hand, by problem settings that are external to
science [26]. However, we do not understand problem
orientation in the sense of the direct intervention of soci-
ety into the sciences. Rather, we consider problem orien-
tation as external requirements that disciplines perceive
and accept in a system-specific way [27].
For toxicology the following constellation results: On the
one hand, problem orientation and context sensitivity,
particularly with respect to (future) nano-technologies,
contribute to the fact that toxicology has a substantial role
to play in cognitive, institutional and social respects. The
nanosciences could profit from institutionalizing toxicol-
ogy, whose research directly meets the social requirement
of security, as an already finalized partial discipline within
the new interdisciplinary field. With the present close
interconnection between the (nano-) sciences and society,
this arrangement could allow toxicology to ascend from
an auxiliary science into an increasingly constitutive posi-
tion within the nanosciences [28]. In order to put into
perspective the estimations and strategies of toxicology in
this challenging state of transition, we revert to two fur-
ther concepts: 'thought-style/Denkstil' and 'boundary
work'.
In order to understand the development of scientific dis-
ciplines in light of the above mentioned aspects, theories
that understand academic knowledge production as the
collective achievement of a community of scientists in a
particular research field will prove helpful. Such 'thought
collectives/Denkkollektive' are representing assumptions
and conditions, under which they are building up a cer-
tain knowledge, a prevailing doctrine and, in the termi-
nology of Fleck, a 'thought style' [29]. According to Fleck,
knowledge is never possible on its own, but only in the
context of various presuppositions about it. Therefore,
disciplines represent thought collectives whose style of
thinking is shaped by their surrounding social, political
and cultural context [30].
In periods of transition between thought styles, 'Denkstil-
wandel', the collective is not consolidated. No commonly
shared views exist. In this phase no uniform thought styles
can be identified; the collective shaping of identities is in
flux. Cognitively and institutionally it is still unclear
where the development will lead. Such considerations are
also helpful for our study: In the phase of the 'nano-scien-
tific challenge' we expected to find a variety of different
positions and estimations of the present and future role of
toxicology within or outside of the nanosciences.
Therefore, a third concept; that of 'boundary work' is help-
ful for describing the various possibilities that result from
that assumption [31]. Thomas Gieryn has developed the
concept of 'boundaries' to describe textual as well as insti-
tutional demarcations between 'science' and 'non-science
' [32]. In accordance with the concept of finalization (cog-
nitive, institutional, social aspects, shaping the develop-
ment of disciplines) mentioned above and the anticipated
heterogeneity of the thought styles of scientists working
inside a transforming field, the point of boundary work
lies in the fact that the fixing of boundaries depends on
contextual factors such as which the topics, questions and
methods belong to 'our' field and which do not. Using the
'boundary work'-concept, we hope to show, in the case of
toxicology, how scientific fields form their disciplinary
identity by setting boundaries between new and old
research fields.
Against this background, we will analyze toxicology as a
scientific discipline, which is establishing itself within the
Finalization-concept: three aspects, influencing the develop- ment of science and scientific disciplines Figure 1
Finalization-concept: three aspects, influencing the develop-




Institutional aspects: internal processes within
scientific institutions (cooperation,
communication, interpersonal relationships)
science as a social operation system,
differentiation of new research fields
Cognitive aspects: internal
structure of science and epistemic
practices (how academic
knowledge is produced)
External aspects: science-policy attitude and 'product value
orientation' (political, social and economic interests orientated
toward the solution of specific, socially induced and politically
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field of nanosciences and -technologies. Herein, we are
interested in what way toxicologists are producing their
knowledge and how involved researchers assess their pro-
fessional identity. Furthermore, we will analyze the cogni-
tive, institutional and political aspects, shaping the
disciplinary development. Herein, we will put a particular
focus on the shifting thought styles of the particle toxico-
logical community and their setting of boundaries with
regard to the emerging fields of nanosciences and -tech-
nologies.
Hence, our hypothesis is that the disciplinary identity for-
mation of toxicology, set against the background of its
entrance into the nanosciences and -technologies, repre-
sents a still open-ended and rather incremental scientific
development.
Methods
For the analysis of disciplinary identity-building proc-
esses, we selected a qualitative sociological research
approach, based on the method of 'grounded theory' [33].
It consists of a case study analysis [34] within the research
field of particle- and inhalation toxicology and an empir-
ical study. We also worked with qualitative interviews and
the problem-centered interview method [35]. This allows
for the combination of narrative elements with a manual
structure, which enables the consideration of background
knowledge [36]. In our research we interviewed fifteen
leading scientists from Germany, Holland, Switzerland
and the USA, all of whom are analyzing the potential
health impacts of nano-scale particles. We recruited our
interview partners through the method of'theoretical sam-
pling' [37]. With this method we did not chose a repre-
sentative sample following the usual criteria of sample
selection, e.g., the coincidence principle. We rather
selected persons, participants, and representative institu-
tions, with regard to their potential for contributing to the
research project. Hence, neither the extent nor the charac-
teristics of the sample were fixed in advance. In addition,
theoretical sampling allows the selection of new partici-
pants, whose relevance only shows up during the research
process. Sample selection was terminated when theoreti-
cal saturation was reached [38]. Theoretical saturation is
reached when the insights gained per additional interview
declines.
Qualitative research, and the approach of 'grounded the-
ory' distinguish themselves in not working with prelimi-
narily defined variables. Rather, the analytical codes are
directly extracted from the interview-sequences. Along
those codes, which build up the subsequent result section,
the arguments are worked out [39].
Results
Knowledge-production and disciplinary identity formation 
in toxicology
Following a historic overview at knowledge-production in
toxicology, we will present our views on disciplinary iden-
tity formation in toxicology through a discussion of cita-
tions from our interviews.
Knowledge-production in toxicology
In this chapter, we will give a historical overview at the
development of toxicology and its three-phase transfor-
mation into a scientific discipline. Furthermore, we will
focus on the specific methods and practices with which
toxicological knowledge-production enters the nano-sci-
ences. Selected quotations from our interviews will be
used to illustrate how toxicological identity formation is
challenged by the cooccurrence of a previous, historically
grown technical self-understanding (thought style) as well
as the new requirements of participating in the nano-sci-
ences.
Traditionally, toxicology examines the potentially harm-
ful effects of chemical or physical agents for biological sys-
tems. It is also called the science of the poisons [40].
During its transformation into a scientific discipline, tox-
icology went through three phases: In the first phase, the
health effects of selected substances were observed. First,
toxicologists wrote down a phenomenology of poisons
and remedies. The roots of such phenomenologies of poi-
son can be retraced in the origins of the development of
human medicine. In antique European, Arabic and Asian
cultures, knowledge of toxic substances was inseparably
linked with medical training and practice [40]. Further-
more, the science of toxin was closely linked to botany
and the plant sciences in ancient Greece. Theophrastus, a
Concept of thought collectives and thought styles Figure 2
Concept of thought collectives and thought styles. Scientific 
disciplines represent thought collectives with a particular 
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pupil of Aristotle (372-287 BC) composed botanical
works and gave detailed descriptions of medicinal and
poisonous plants. His work has been designated as the
beginning of modern botanies. Arab cultures developed
chemical approaches in toxicology. In the Middle Ages,
mainly southern European physicists like Maimonides
(1135–1204) and Pietro de Abano (1250–1316) contrib-
uted to the identification of poisons [40].
A second phase covered the experimental approaches,
used to examine the mechanisms of dose effect depend-
ence. Paracelsus (1493–1541) is considered the founder
of this phase. In the 16th century he developed a concept
of poison, which is still applicable today. He thereby ini-
tiated a turn away from a merely descriptive analysis of
phenomena and the categorizations and listing of poisons
then found in experimental and analytic research
approaches. Furthermore, he began to use his knowledge
for therapeutic applications, that is, he used 'poisons' for
beneficial effects. The knowledge gained in a variety of sci-
entific and medical disciplines supported the transforma-
tion of toxicology in the 18th and 19th centuries from
knowledge-production based on experience into a con-
cept-based scientific field [41]. In the early 20th century,
toxicology was established as a natural scientific discipline
clearly demarcated from pharmacology, medicine, chem-
istry and biology [40]. In a third phase, toxicology
increased in relevance through its emergence as a testing
discipline and attendant research science. This happened
in the second half of the 20th century in the context of
intensive scientific and technological growth, accompa-
nied by hazardous incidents and social controversies.
Through the development of guiding principles for the
regulation of toxic chemicals, work place safety and public
health, toxicological knowledge became useful for politics
and policy-making in various industrial nations. With its
knowledge of the health and environmental effects of new
materials and substances, based on quantitative labora-
tory studies, toxicology developed a comprehensive net-
work for the measurement and categorization of the dose-
effect-dependence of the most prominent industrially
used materials. The investigation of the toxicity of parti-
cles is closely linked historically to mineral fibers like
asbestos and industrial activities, like coal mining. Thus,
the European community for steel and coal (ECSC) con-
tributed to the establishment of the research field of parti-
cle toxicology [42]. By developing concrete, measurable
testimony about risk and safety, toxicology established
itself as an attendant, testing discipline and monitorial
authority. They are cover the identification, quantification
and prevention of the unfavorable side-effects of chemi-
cals. In addition, safety regulations for job descriptions,
and tolerance limits for chemical additives in food and
water were determined [43]. Hence, as one interview part-
ner holds, toxicology became dependent on industry and
politics. Toxicology needs research funds from industry
and politics, which in turn need applicable toxicological
knowledge.
"For politics and industry our research is absolutely relevant
and necessary. Therefore we need their support." (Toxicologist
II, German research center)
Knowledge-production within toxicology mainly focuses
on quantitative in-vitro and in-vivo studies [44]. In-vitro
studies cover laboratory studies of cell lines which are spe-
cially bred under variable conditions. In-vivo studies
focus on the reaction of the organism as a whole to the
admission of and exposure to certain substances. They
mainly involve animal tests with conventionally bred or
transgenic rodents in the laboratory and, to a more mod-
est extent, clinical trials with humans, as a researcher at a
Swiss university, working in the field of inhalation toxi-
cology, holds:
"Our possibilities to conduct studies with humans are extremely
limited. Therefore, we try to develop models. In-vivo, I have
been working with small rodents, like rats and hamsters.
Recently, I have also started to work with mice. In particular, I
use transgenic mice, which I consider a very good model for spe-
cific questions. With the second model we are trying to recon-
struct respiratory epithelia in- vitro, in order to observe particle-
lung interactions." (Biologist II, Swiss university)
Toxicology represents an interdisciplinary research field. It
uses up-to-date methods and techniques, which overlap
with neighboring disciplines like chemistry, pharmacy
and medicine. Since the 1990s it has also become
involved in the field of molecular biology. At the same
time, it underwent a paradigm-shift in its research practice
from high to deep dosages [45]. In the opinion of several
toxicologists, particularly in Europe, toxicology's interdis-
ciplinary character is a crucial precondition for doing
research on particles at the nano-scale level:
"We work together with the material sciences, with chemists,
physicists and engineers. Furthermore, the topic is connected
with meteorology and thermodynamics. In toxicology, the spec-
trum is even broader. The classical toxicologist is usually a biol-
ogist, biochemist, bio-physicist, pharmacist or bio-engineer.
And epidemiology goes together with pure mathematics, partic-
ularly in the case of statisticians and epidemiologists, who have
a medical or a scientific background, for example physics or
chemistry, but primarily medicine." (Toxicologist I, German
research center)
Discussion
Toxicology thus established itself in the late twentieth cen-
tury as a classicalexamination discipline and testing sci-
ence in the course of efforts of various industrial nationsParticle and Fibre Toxicology 2006, 3:6 http://www.particleandfibretoxicology.com/content/3/1/6
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to regulate toxic chemicals. Research questions within this
field focus on current social and political issues. The adap-
tation of its research agenda to external problem defini-
tions enables toxicology to focus on a problem- and
application-oriented form of knowledge-production,
which incorporate the latest approaches and practices.
Relevant scientific investigations of the bio-reactivity of
industrially manufactured particles on the nano-scale
level, and concrete statements about their health implica-
tions, have enabled toxicology to establish itself as a lead-
ing discipline. The forms and functions of toxicological
knowledge production are relevant in a time when society
demands consideration of its own requirements. Toxico-
logical research promotes ends that are not only profita-
ble, but also result in safe products and procedures. Here,
the subdisciplines of particle- and inhalation toxicology
in particular play a central role [42]. The research field of
particle toxicology, as a subdiscipline of toxicology, devel-
oped in the context of the study of lung disease, particu-
larly as it occurs in the mining industry [42]. The central
organ of a particle or inhalation toxicological approach is
the lung. Furthermore, mainly insoluble materials are
analyzed and scientists often work with traditional toxico-
logical methods and approaches [42]. In the course of
intensifying concern over air pollution, exhaust fumes
and smog, the research field of particle toxicology gained
in importance.
As a problem-oriented science, toxicology gets the chance
to move in the periphery of problem-oriented but still not
yet sufficiently formed cutting-edge research in the nano-
sciences and to profit from research funds within these
fields. Nevertheless, in societal discourse, in the media
and in politics, toxicologists are considered the experts
with regard to the relevant questions. In our entire
research area we found only two research groups, focusing
on the health risks of particles in the nanometer scale,
which did not characterize themselves as toxicologists.
Nevertheless, these groups are methodologically, textually
and technically working closely together with toxicology
and in close exchange with toxicological working groups.
They distinguish themselves from toxicology, arguing that
they, unlike toxicology, examine entrance mechanisms by
which particles enter into the body and do not focus on
material effects within the organism. Furthermore, they
claim to work with deeper and more realistic dosages and
a minimum number of laboratory animals. Nevertheless,
they produce knowledge comparable to that produced by
toxicological working groups. Press coverage on the
health risks of particles in the nanometer scale mainly
focuses on toxicologists as the experts in this field [46].
Shaping disciplinary identities in toxicology: cognitive, 
institutional and external aspects
In our study, we found three aspects shaping the discipli-
nary identity of toxicology against the background of its
entrance into the research field of the nanosciences and -
technologies. First, science-internal factors like cognitive
and institutional aspects play an important role. In our
study, we understand cognitive aspects as research objects,
approaches, research- and everyday-practices and result-
ant findings. Institutional aspects cover scientific contexts,
like access to research funds and the reputation of a disci-
pline. Under external aspects (orientation to social prob-
lems) we subsume negotiation processes in matters of
definition and orientations to therapeutic approaches. We
will group our results around these three aspects, and
include quotations from our interviews.
Cognitive aspects: risk research as tradition and transition
The health effects of particles on the nanometer scale, dis-
cussed in science, politics, the media and by the public,
are comparable to the risk concepts of toxic chemicals.
Through the analysis of the toxicity of chemical sub-
stances, comparable approaches are selected and similar
insights are achieved. When compared to a variety of
materials, pollutants and substances being deposited into
the environment, the discussed health effects of nano-
scale material display their chronic toxicity. This, and its
longtime research experience with particles on the
micrometer and ultrafine level has enabled toxicology to
establish itself as a scientific discipline in the risk analysis
of particles on the nanometer scale [47]. The analysis of
the health implications of ultrafine particles in laboratory
trials took place with well-defined, specially produced ref-
erence particles. The use of reference particles enabled the
comparison and reproduction of particular test arrange-
ments. Such reference particles are similar to today's
industrially manufactured nanoparticles. An interview
partner, who has been working for over thirty years in this
field, stressed that toxicological groups already worked
with nano-particles before the term 'nano' was estab-
lished.
"For us, the term 'nano' is old hat, we have always been 'nano'
now for more than 10 years, although we did not use the term
'nano'." (Toxicologist I, German research center)
Toxicology established itself in the analyses of health
implications of micrometer particles in the last thirty
years. A close methodological and textual connection
exists between research on unintentionally and combus-
tion-produced ultrafine environmental particles and well-
defined selectively produced particles on the nanometer
scale. Particularly, experience from the analysis of the
health impacts of particles on the micrometer scale is seen
by several interview partners as a central precondition forParticle and Fibre Toxicology 2006, 3:6 http://www.particleandfibretoxicology.com/content/3/1/6
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doing research with particles on the nanometer scale, as
another toxicologist from a German research center holds:
"I started with micrometer particles. 98% of my knowledge and
experience is based on micrometer particles. [...] thirty years
ago, I was concerned with particles, sized between 0.5 and 5
micrometers. And then the ultrafine particles came up. That
was ten years ago and since then I have been doing something
similar with the ultrafines." (Toxicologist III, German research
center)
Besides work with particles on the micrometer scale, con-
stitutive research on ultrafine particles supplied important
insights and preconditions for working with selectively
produced particles on the nanometer scale. Based on their
experience with the bio-interactions of those particles,
several interviewpartners are disclosing the behavior of
selectively produced nano-particles.
"The industrially manufactured nano-particles are materially
comparable to environmental particles. Therefore, research
within these fields can well be combined. [...] Our experience
with ultrafine particles is of high importance for analyzing the
risks of nano-particles. Along with ultrafine particles, we began
to use nano-test particles to investigate certain mechanisms."
(Toxicologist II, German research center)
The transition from the 'ultrafine-' to the 'nano' scale
often happens inconspicuously. Alongside research with
ultrafine particles, similar experiments are repeated with
selectively produced nano-particles. As a rule, however,
particularly the German research groups, we analyzed,
sought a clean distinction between established and new
research fields.
"I don't want to give the impression that we are only working
with ultrafine dust, with combustion stuff. We also work with
the typical synthetic nano-particles [...] thus, we do both: We
work both: on the combustion side with fly ash and environ-
mentally relevant particles as well as with nano-technological
particles. We clearly divide this into two different projects, with
the appropriate nomenclatures. "(Toxicologist IV, German
research center)
Most insights into the potential health effects of particles
on the nano-scale level have resulted from toxicological
approaches, on methods, and were achieved in toxicolog-
ical research groups and laboratories. The most frequently
observed health effects and bioreactive phenomena of
materials on the nanometer scale are inflammatory cell
reactions resulting from the deposition of such materials
in the lung [48]. The transport of nano-scale particles
through the lung into the blood was also observed [49]. In
addition, the particles were found deposited in the body
and to have even overcome the blood-brain barrier [50].
In fact, nano-scale particles were found in all organs of the
body [51]. This fact was also reported by a researcher in
the field of inhalation toxicology at a Swiss University:
"We found the particles distributed in the entire lung four hours
after their admission. Furthermore, we found them in the
blood, from where they can easily be distributed into the whole
organism [...] a colleague of mine at the GSF in Munich found
particles in the liver, in the kidney, in the heart and even in the
brain. Epidemiological studies have shown that with accumu-
lating concentrations of fine dust in the air, certain diseases,
such as cancer, and heart, circulation and respiratory problems,
are increasing." (Biologist I, Swiss university)
Furthermore, some results show that nano-scale particles
are transported into the brain by olifactory nerve cells [52]
and are involved in neurodegenerative changes [53]. The
same researcher continues:
"Nano-particles are transported along the olfactory nerves into
the brain. We do not know what happens there. Besides that,
there is a study showing that the histological picture of Alzhe-
imer patients, who died at the age of 70 or 80 years, closely
match a picture of the brain of accidentally killed 30 year old
persons who lived in areas with a strong particle-load. "(Biolo-
gist I, Swiss, University)
A research group at the GFS – Research Center for Environ-
ment and Health (in the Helmholtz community) in Neu-
herberg near Munich developed a technique for
quantifying the health implications of particles within the
nanometer scale. It conceives of risk and a shortening of
lifetime and expresses this in the number of lost life years
[54]. Thus, the risk is constructed through the 'lifetime-
shortage' factor as a measurable, conceivable and concrete
quantity. A researcher of this group argues:
"According to our epidemiological studies, long-term exposure
with high concentrations of environmental aerosols can shorten
a life span by one year. In Germany, between 4'000 and
10'000 persons per year are affected." (Toxicologist I, German
research center)
Discussion
In summary, we argue that, in this early phase of identity
formation, toxicology strongly relies on current methods,
practices and approaches. In parallel with its well-estab-
lished analysis of the health effects of particles on the
nanometer scale, toxicology is building for itself a new
research field through its analysis of the potential impacts
of nano-scale particles. Entering into this field, toxicology
brings with it basic knowledge from the analysis of
micrometer and ultrafine particles. In this way, the transi-
tion to a new field proceeds incrementally; this careful
movement is particularly well-articulated in the quota-Particle and Fibre Toxicology 2006, 3:6 http://www.particleandfibretoxicology.com/content/3/1/6
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tion: "we have always been nano". This is as it were, the
secured position from out of which nano-specific ques-
tions and procedures can be necessarily conceded. In the
next section we will address the question of how – along-
side the cognitive aspects -institutional conditions, like
funding acquisition strategies and the reputation of toxi-
cology as a science, are also shaping disciplinary identities
in this research field.
Institutional aspects: acquisition and reputation
Besides the cognitive conditions, discussed in the previous
section, institutional aspects are also shaping the forma-
tion of the disciplinary identities of toxicology in the con-
text of its entrance into the research field of nanosciences
and -technologies. The increasing scientific, political and
economic interest in nanosciences and -technologies have
opened considerable funding sources for this field. Thus,
research projects for the investigation of the health impli-
cations of industrially manufactured nano-particles are
usually more generously supported than similar investiga-
tions of particles originating from combustion processes.
For this reason there is an interest in expanding the
research breath of the nano-sciences, as a toxicologists of
a German research organization holds:
"If you write the term 'nano' into your research grant applica-
tions, the probability to get funding is much higher than if you
use the term 'ultrafine'."[...](toxicologist, German Univer-
sity)" 'Nano': this is a fashion and naturally also a proposal
strategy. If I applied for research funding on ultrafine dust at
the European Union, that would be old hat. It was already done
in the 1970s and the 1980s. However, if I applied for funding
for a project on the influence of nano-particles, then everything
looks quite different." [...] (Toxicologist II, German research
center) " Furthermore, it was a question of funding. In the
European Union, research on ultrafine particles was promoted
less after 'nano' emerged and, since then, we have also been try-
ing to get funding for 'nano'." (Toxicologist I, German research
center)
Besides funding strategies, toxicology's traditional histori-
cal role as a testing science enabled it to also enter into the
new research field. The increasing growth of research and
development within the nanosciences and -technologies
made risk assessments inevitable. Hence, different mate-
rial research institutes established research groups in toxi-
cology as an accompanying testing science. Furthermore,
they involved toxicology within their own field. As a Ger-
man toxicologist argues, toxicologists were expected to
analyze the potential health implications of materials on
the nanometer scale, which are researched and developed
within these institutes.
"Our research institute has laboratories for nano-technology,
material research and chemistry that are working with nano-
materials. Our task is to accompany those technological devel-
opments with toxicological research." (Toxicologist II, German
research center)
In its role as an attendant testing science, several toxicolo-
gists, particularly in Germany but also in Switzerland
complained of toxicology's lack of prestige. Since their
research aims at discovering potential hazards, they are
only able to publish their data if they have found a health
effect for a substance or a product. As this is socially per-
ceived as unfavourable, they feel themselves to be the
bearers of bad news. In our interviews, we detected a cer-
tain disillusionment. In particular, toxicologists seem to
lack the possibility of publishing socially favourable
results such as that for a certain substance or product no
danger could be proven, in renowned high-impact jour-
nals. Furthermore, some toxicologists expressed discon-
tent with their financial situation and their lack of
scientific and political appreciation. Hence, among toxi-
cologists, particularly in the German research community
the view dominates that productive disciplines enjoy a
higher reputation and can publish their research results
more easily and in higher-rated journals, as German toxi-
cologists argues:
"If you work in toxicology, you only have negative results."
[...](Toxicologist II, German research center) "My highest goal
would be to get a safety study published in Nature. That is the
problem, we can only publish negative effects. When we find
positive, or rather no, effects, we cannot publish them. When
we discuss that a particular substance is not toxic, this is fine
for society but bad for us as scientists, since we measure research
quality based on output. If a geneticist finds a new gene, a new
gene product or a regulator in his laboratory, then he has a new
paper. This is very simple. And the paper, if this is a basically
important process, will be accepted in Science, Nature or some-
where else. This is not possible in our field. If we tested ten sub-
stances and they all turn out to be harmless, then we have just
spent five years without publishing anything. As a toxicologist
you hardly ever want to be in Nature or Science. Being there,
you must have found a substance so toxic that you would prefer
it did not exist. That is the difficulty with toxicology. But
nobody recognizes that. The investors do not realize that, and
neither do our clients nor society. Everybody says: Toxicology is
expensive and brings nothing – from an economic perspective."
(Toxicologist III, German research center)
Like ethics, toxicology assists neighboring disciplines in
an accompanying and advisory way. It is basically a testing
science. By turning its attention to risk, it often sees itself
as being ill-reputed as a brakesman, a spoilsport, a critic or
an unloved child. For toxicology, this role is unappealing.
According to some interviewed German toxicologists, pro-
ductive disciplines seem to undervalue the constructiveParticle and Fibre Toxicology 2006, 3:6 http://www.particleandfibretoxicology.com/content/3/1/6
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aspect of toxicological knowledge production, as another
German toxicologist argues:
"Toxicology is usually seen as a brakesman and spoilsport. Tox-
icology focuses on implications that an engineer does not neces-
sarily see, but which could be of great importance for him. This
means that there absolutely is a knowledge gain resulting from
the analysis of hazardous implications. Toxicology should be a
constructive element with the development of nano-technolo-
gies. Collaborations between developers and those who focus on
implications are crucial. If this happens at as early a stage as
possible, then this is – according to my perception – no handi-
cap, but rather a moment of creative research, positively stimu-
lating the whole process." (Toxicologist I, German research
center)
Discussion
Institutional aspects like finding acquisition strategies and
toxicology's traditional role as a testing science enable its
entrance into the research field of nanosciences and -tech-
nologies. Moreover, the toxicological research community
expresses the desire for higher outside appreciation. Toxi-
cology aims at constructively accompanying and crea-
tively influencing controversial cutting edge research.
Furthermore, toxicology prefers the role of the productive
partner rather than the brakesman. This aim represents
kind of a crucial test – at least in terms of the transitional
phases for evolving disciplinary identities. While the brak-
ing and warning function belongs to its classical scope,
toxicology nevertheless fears that it will not even be able
to fulfil those functions. Thus the question occurs,
whether these functions detract from ('spoil sport') or
support toxicology's disciplinary reorientation, since it
now sufficiently fulfils social requirements for safety. We
will focus on this still undecided question under the title
of problem-orientation in the next section. In doing so,
we will also analyze the impact of toxicological participa-
tion in the therapy-oriented research of the nanosciences.
External aspects: problem orientation and negotiation 
processes
Besides those aspects internal to science, orientation to
science-external research questions and problems also
shapes the disciplinary identity of toxicology. One impor-
tant example is the orientation of toxicological knowl-
edge-production toward nanoscientific approaches to
therapeutic issues in pharmacology. The aim of this
research area is the development of mobile drug carrier
systems based on nano-particles. Here, nano-particles are
used as transport systems for therapeutic agencies. Due to
its specific characteristics, a medication can be directly
applied to the effected location in the body [55]. Toxicol-
ogy can adapt its insights into specific particulate and
material properties and structures, developed in in-vitro
and in-vivo studies, to the production of bio-inert parti-
cles with minimal health effects. Besides its function as a
testing discipline, toxicology has the opportunity to adapt
is knowledge to the health implications of particles on the
nanometer scale range to the production of particles, for
therapeutic use in pharmacology, which do not verifiably
harm biological systems. We found this argument in the
European as well as in the US-context.
" 'Nano' offers an enormous potential for toxicology. For exam-
ple, we are able to develop bio-inert particles." [...] (Toxicolo-
gist, US-university) "A positive approach is therapy. This is, at
the moment, a good idea, and one for which we have filed a
project application. We will not examine any particular thera-
peutic aspects, but will rather aim at finding out how a nano-
particle should be designed, and what surface properties it must
have in order to not cause any reaction in the organism. If I cre-
ated such a particle, I could load it with a medicament or equip
it with receptors such that these would then be carried into the
cells. The real positive thing about this approach is that you can
in the end, use it therapeutically, for example, in tumor ther-
apy. You can attach to these cells through certain receptors,
which the tumor is expriming. It will be absorbed into the cell
and the agent will then be developed specifically in the tumor
cells. In contrast, simplifying things, conventional chemothera-
peutic agents are simply given to the organism and the tumor
cells are more intensely damaged than the normal cells, as they
have a higher turn-over. I would see this as a positive aspect of
toxicological research." (Toxicologist IV, German research
center)
Besides the therapeutic orientation, definitorial demarca-
tions seem to be another externally induced influence on
disciplinary identity shaping in toxicology. In particular,
the toxicological research community does not share a
uniform attitude regarding the question of when a particle
can be called a 'nano-particle'. While one part of the com-
munity argues for a merely size-oriented definition, others
demand an origin-oriented distinction. Through this con-
troversy, discussions and negotiation processes are devel-
oping concerning the demarcation of the research field of
the nanosciences and -technologies. Part of the toxicolog-
ical research community is using a purely size-oriented
approach and is including all particles within the nanom-
eter range (with at least one dimension smaller than 100
nanometers or 10-7-10-9m) under the term 'nanoparticle',
as toxicologists in Germany and in the Netherlands
argued.
"Nano particles are particles which are at least in one dimen-
sion smaller than 100 nanometers. Through this, also nano
tubes and plane particles are also incorporated. With the
ultrafine, all three dimensions must be smaller than 100
nanometers. Therefore, we are classically ultrafine and to that
extent also nano. Because ultrafine is always nano as well."
(Toxicologist I, German research center)Particle and Fibre Toxicology 2006, 3:6 http://www.particleandfibretoxicology.com/content/3/1/6
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This enables the researchers involved to call their research
on ultrafine particles 'nanoscience', and to partake of the
rich funding opportunities in this field (see also section
4.2).
Toxicologists who plead for an origin-oriented distinc-
tion, argue that randomly emerging particles on the
nanometer scale, usually resulting from combustion proc-
esses, should be called 'ultrafine-' or 'ambient air parti-
cles'. Furthermore, such particles usually consist of
complex material mixtures. Only industrially manufac-
tured, materially clearly defined particles within this size-
range ought to be called 'nano particles'. We found this
argument as well in the European than in the US context.
"Concerning nomenclature at the very least the basic need for
a distinction between clearly defined, engineered nanosized
particles and those accidentally released into the environment,
should be met [...] Defining complex material mixtures, I'd
rather use the general term 'ultrafine particles'. For engineered
materials, I would use the term nano-material. The term 'nano-
material' implies technical design and intentional manufac-
ture. The size range of particular ultrafine particles only coinci-
dentally lies in the nanometer scale. Therefore, I would use
terms like 'combustion particle' or 'environmentally relevant
particle' for particles unintentionally released into the environ-
ment, and definitely not the term 'nanoparticle'." (Toxicologist
II, German research center)
As a compromise between the two positions, other mem-
bers of the toxicological research community suggest the
use of the term 'nano-scale particle' for both kinds of par-
ticles. This still size-oriented concept permits research in
the field of ultrafine particles to be included under the
term 'nano', and it allows such research to profit from the
considerable research funds available to the nanosciences.
At the same time, this definition is seen as allowing the
desired demarcation for public-risk discourse.
"Therefore, I'd suggest the term 'nano-scale particle' as a com-
prehensive definition for environmental particles within the
nanometer scale. "(Toxicologist, US-university)
Discussion
The openness of the term 'nano', and the vague bounda-
ries of the nanosciences and -technologies leave consider-
able space for toxicology to form its own disciplinary
identity. Research fields, like the analysis of the health
risks of ultrafine particles, can be subsumed under the
'nano-sciences'. The definitions used so far are set less for
scientific than for political reasons, such as funding acqui-
sition strategies and carreer interests. Hence, it is feared
that a merely size-oriented definition could transfer pub-
lic concerns over the health effects of ultrafine particles
onto the entire area of the nano-sciences. This would,
according to some, provoke public resistance to the nano-
sciences as such. Therefore, there is an interest in narrow-
ing the research field of the nanosciences. Yet such
demarcations also decide, whether another, quite relevant
discipline (here: Toxicology) should obtain access to what
is distinguished as a key technological field, and so also to
the considerable research funds available to that field. In
the negative case, toxicology would remain a less spectac-
ular side-field with more modest funds. Therefore, the
term 'nano' is not only rewriting a research field, with its
specific questions and methods, but it also acts as a fund-
ing acquisition strategy and a reputation boost for indi-
vidual researchers and groups. The entry of toxicology
into the nano-sciences is enabled not only by its long
research tradition in the analysis of the health implica-
tions of environmental and combustion particles on the
micro- and nanometer scale, but as much by its taking
advantage of an ambiguity by definition and vague
demarcations of the research field of nanosciences and -
technologies
Besides the social negotiation of definitioned demarca-
tions, orientation to social issues also plays a substantial
role in shaping disciplinary identities in toxicology. By
participating in the development of therapeutics, like
medical transmitter systems, toxicology sees a chance to
leave behind its cognitively less attractive status as a purely
evaluative field, and to develop from a classical testing sci-
ence into a productive discipline. The entrance into the
research field of the nanosciences and -technologies is
seen as an opportunity for toxicology to transform its dis-
ciplinary identity and its mode of knowledge production.
Whether such a transformation is actually taking place,
and is introducing a new disciplinary identity, and
whether toxicology will establish itself as a productive
nanoscience, will be discussed in the final section.
Conclusion
Toxicology as a nanoscience?
The establishment of socially highly esteemed research
fields opens up possibilities for a variety of scientific dis-
ciplines to participate within innovative research ques-
tions and partake of available research funds.
Controversial issues like the potential risks of nanoscien-
tific research, open the field to disciplines like toxicology
that are qualified in the analysis of such issues, due to
their cognitive and institutional background. By entering
the emerging field of nanosciences and -technologies, tox-
icology is not only faced with the question of its contribu-
tion to current social debates on potential risks, but
furthermore – and this is the central theme of our article
– also with implications for its own disciplinary identity.
Is toxicology or will it become, one of the constitutive
nanosciences and -technologies?Particle and Fibre Toxicology 2006, 3:6 http://www.particleandfibretoxicology.com/content/3/1/6
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Within the field of the nanosciences and -technologies,
toxicology is contributing significantly to risk research
through its epistemic and ontological tradition as a testing
science. In this, its orientation toward externally given
problem definitions, such as the supply of concrete state-
ments on the health implications of particles within the
nanometer scale as a basis for potential regulation, plays
an important role. Problem orientation and context sensi-
tivity, particularly toward (future) nano-technologies,
enables toxicology to undertake an identity-shaping role,
from a cognitive, institutional and social perspective.
However, in this phase of the 'nano-scientific challenge',
different positions and perceptions exist on the current
and future role of toxicology within or outside of nano-
sciences. Hence, the formation of toxicology's disciplinary
identity is shaped by cognitive aspects, such as its long
research experience on the health effects of different mate-
rials, and its production of practical knowledge bases. Fur-
thermore, institutional aspects, such as funding
acquisition strategies and questions of reputation are
shaping its disciplinary identity. Currently, toxicology
finds itself in a transitional phase. The development of its
disciplinary identity is incremental, open-ended and
underdetermined.
All of our interview partners stressed the necessity of repo-
sitioning toxicology. However, they all suggested most
different approaches. While some exponents of particle
toxicology are already propagandizing the establishment
of a new discipline -'nanotoxicology'- others are more
reserved and demand a clear separation between tradi-
tional and new research areas. Furthermore, some toxicol-
ogists are afraid of encouraging social controversies over
the potential risks of nanotechnologies. Hence, they aim
to demarcate the field of nanosciences and -technologies
on the basis of terminology. However, this competes with
the interests of neighboring disciplines, also interested in
benefiting from the research funds available within this
field.
In both cases, aspects of 'boundary work' can be observed.
By expanding its boundaries, participating in new
research fields, continuing its traditional research, and
only vaguely defining its research area, toxicology is trying
to find its way into the new field without giving up its cur-
rent disciplinary self-conception. Hence, there are a vari-
ety of possibilities: Alongside a general technical
reorientation (change in thought-style), it is equally pos-
sible, if not even more probable, that toxicology is
responding with external and internal differentiation.
Thus, it faces current challenges (nanotoxicology) without
neglecting its traditional expertise (toxicology as a testing
science). Why choose when you can have both?
The development of a discipline into a new research field
is shaped by science-internal aspects (cognitive and insti-
tutional) as well as by an orientation toward external
problem definitions. In the transitional phases of discipli-
nary development, research communities do not act con-
sistently. Rather, they establish diverse options by
canceling definitional, epistemic and ontological bound-
aries. The fact that toxicological knowledge of the bio-
reactivity and material behavior of a variety of substances
and materials can be put to therapeutic uses, plays a sub-
stantial role. In particular, this therapeutic orientation
enables toxicology to transform from its traditional role as
an attendant and testing science into a 'productive' disci-
pline. In this way, toxicology can 'ascend' from being an
auxiliary science into a tendentious constitutive position.
The question of whether context and the disciplinary
requirements of certain problems not only enable the
establishment of a discipline within an influential
research field, but, was assumed in the case of the thera-
peutic orientation of toxicology in the nano-sciences, also
lead to a transformation within the previous discipline
cannot be answered completely. The positions currently
vary. This is also the assessment of Vicky Colvin, who sees
the role of toxicology in the nanosciences as one between
"gatekeeper" and "player". According to her: "The para-
digm shift really is not seeing toxicology as a gatekeeper
but seeing toxicology as a point of information that allows
you to generate more biocompatible materials" [56].
Nevertheless, we assume that also here the shaping of dis-
ciplinary identities will proceed incrementally and oppor-
tunistically. This will not only happen through a
comprehensive new formation of toxicology in the sense
of a paradigm-shift (nanotoxicology) and not only
through the expansion of its classical scope (toxicology as
a testing science also within the field of the nanosciences
and -technologies). Rather, this will happen through
internal differentiation i.e., both of the above as well as
external differentiation. Hence, it is possible that individ-
ual researchers or research groups working in toxicology
will migrate into neighboring disciplines like 'pharmacy'
or 'nano-medicine'. Everything still seems possible, and
everything at the same time: Why choose when you can
have everything?
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